KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Common Equity (2016 - 2026)

Boston Scientific's Common Equity history spans 18 years, with the latest figure at $26.1 billion for Q1 2026.

  • On a quarterly basis, Common Equity rose 16.3% to $26.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $26.1 billion, a 16.3% increase, with the full-year FY2025 number at $24.5 billion, up 12.41% from a year prior.
  • Common Equity hit $26.1 billion in Q1 2026 for Boston Scientific, up from $24.5 billion in the prior quarter.
  • Over the last five years, Common Equity for BSX hit a ceiling of $26.1 billion in Q1 2026 and a floor of -$2.3 billion in Q1 2023.
  • Historically, Common Equity has averaged $13.8 billion across 5 years, with a median of $19.5 billion in 2023.
  • Biggest five-year swings in Common Equity: tumbled 103.09% in 2024 and later surged 265475.0% in 2025.
  • Tracing BSX's Common Equity over 5 years: stood at $269.0 million in 2022, then surged by 7160.22% to $19.5 billion in 2023, then increased by 11.47% to $21.8 billion in 2024, then increased by 12.41% to $24.5 billion in 2025, then increased by 6.67% to $26.1 billion in 2026.
  • Business Quant data shows Common Equity for BSX at $26.1 billion in Q1 2026, $24.5 billion in Q4 2025, and $23.6 billion in Q3 2025.